Related Experiment Video
Updated: Sep 17, 2025
13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
10.8K
Sarcopenic Obesity in Adult Patients: Prevalence and Risk Factors
Sana Khamassi1, Fatma Boukhayatia1, Haifa Abdesselem1
1Department of Nutritional Diseases D, National Institute of Nutrition and Food Technology, Tunis, Tunisia.
Nutrition and Metabolic Insights
|June 30, 2025
Summary
Sarcopenic obesity (SO) affects 19% of obese adults and is linked to osteoarthritis and reduced quality of life. Screening for SO is crucial in obese patients to address its health impacts.
Area of Science:
- Gerontology
- Obesity Medicine
- Nutritional Science
Background:
- Sarcopenia, the loss of skeletal muscle mass and function, is a growing concern in the obese adult population.
- Obesity presents unique challenges, potentially exacerbating age-related muscle decline and leading to sarcopenic obesity (SO).
Purpose of the Study:
- To determine the prevalence of sarcopenia among obese adults.
- To investigate the health and quality of life implications of sarcopenic obesity.
- To identify risk factors associated with sarcopenic obesity.
Main Methods:
- A cross-sectional descriptive observational study was conducted on 100 obese adult patients.
- Physical activity was assessed using the Ricci and Gagnon questionnaire.
- Quality of life was evaluated using the SF-12 and ORWELL-97 questionnaires, with SO defined per EASO-ESPEN guidelines.
Main Results:
- Sarcopenic obesity (SO) was diagnosed in 19% of the study cohort.
- SO was significantly associated with osteoarthritis, functional disability, and impaired quality of life.
- Independent risk factors for SO included class 2 obesity, osteoarthritis, elevated triglycerides, manganese deficiency, and reduced physical activity.
Conclusions:
- Sarcopenia screening should be integrated into the management of obese adult patients.
- Addressing sarcopenia in obesity is vital due to its significant clinical consequences and impact on patient well-being.
Related Concept Videos
01:24Obesity
624
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
624
01:28Anorexia Nervosa
206
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
206
01:30Coronary Artery Disease I: Introduction
67
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
01:29Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
01:20COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
119
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
119